Amicogen, Inc. (092040.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.7x

Market Cap

KRW 54.95B

MomentumView details →

1D Return

+2.18%

YTD Return

−43.15%

RSI (14)

46.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.7x

Market Cap

KRW 54.95B

RSI (14)

46.6

MomentumView details →

1D Return

+2.18%

YTD Return

−43.15%

ProfitabilityView details →

Gross Margin

13.79%

Net Margin

−41.34%

EBITDA Margin

−19.28%

ROE (TTM)

−16.35%

ROA (TTM)

−9.78%

Asset Turnover

0.23x

GrowthView details →

Revenue YoY

−60.35%

EPS YoY

+65.74%

FCF YoY

+96.15%

Revenue CAGR 3Y

−33.74%

EPS CAGR 3Y

+43.93%

EBITDA YoY

+60.47%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.50x

Current Ratio

1.04x

Quick Ratio

0.81x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

46.67B

Net Income (TTM)

−19.29B

Op. CF (TTM)

−606.32M

Next earningsDec 14, 2026 →

Latest newsMore news →

No recent news for 092040.KQ.

Similar companies

Pharmaron Beijing Co., Ltd.03759.HK Moderna, Inc.MRNA Encell Co. Ltd.456070.KQ 艾力斯688578.SH Asymchem Laboratories (Tianjin) Co., Ltd.06821.HK argenx SEARGX Find similar companies →

Latest newsMore news →

No recent news for 092040.KQ.